Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Sention Therapeutics, LLC
- Target Recruit Count
- 490
- Registration Number
- NCT05412979
- Locations
- 🇺🇸
Sention Investigational Site, Renton, Washington, United States
News
No news found